Related Articles by Review for PMID: 18711404

Year	Number of Results
2005	2
2006	6
2007	3
2008	4
2009	5
2010	2
2011	1
2013	1
2014	1
2015	1
2017	2
2019	2
2020	1
2021	1
2024	0

1

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. Musunuru K, et al. Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18711404 Free PMC article. Review.

2

High-Sensitivity C-Reactive Protein and Statin Initiation.

Trpkovic A, Stanimirovic J, Rizzo M, Resanovic I, Soskic S, Jevremovic D, Isenovic ER. Trpkovic A, et al. Angiology. 2015 Jul;66(6):503-7. doi: 10.1177/0003319714543000. Epub 2014 Jul 22. Angiology. 2015. PMID: 25053677 Review.

3

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K. Enas EA, et al. Indian Heart J. 2011 May-Jun;63(3):211-27. Indian Heart J. 2011. PMID: 22734339 Review.

4

The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines.

Mora S, Musunuru K, Blumenthal RS. Mora S, et al. Clin Chem. 2009 Feb;55(2):219-28. doi: 10.1373/clinchem.2008.109728. Epub 2008 Dec 18. Clin Chem. 2009. PMID: 19095730 Review.

5

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?

Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. Yousuf O, et al. J Am Coll Cardiol. 2013 Jul 30;62(5):397-408. doi: 10.1016/j.jacc.2013.05.016. Epub 2013 May 30. J Am Coll Cardiol. 2013. PMID: 23727085 Free article. Review.

6

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP. Fabbri G, et al. Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Adv Ther. 2009. PMID: 19444394 Review.

7

Do statins reduce events in patients with metabolic syndrome?

Towne SP, Thara E. Towne SP, et al. Curr Atheroscler Rep. 2008 Feb;10(1):39-44. doi: 10.1007/s11883-008-0007-1. Curr Atheroscler Rep. 2008. PMID: 18366984 Review.

8

The JUPITER trial: How will it change clinical practice?

Watson KE. Watson KE. Rev Cardiovasc Med. 2009 Spring;10(2):91-6. Rev Cardiovasc Med. 2009. PMID: 19593321 Review.

9

Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.

Carter NJ. Carter NJ. Am J Cardiovasc Drugs. 2010;10(6):383-400. doi: 10.2165/11204600-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 21090831 Review.

10

Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Nordestgaard BG, Zacho J. Nordestgaard BG, et al. Nutr Metab Cardiovasc Dis. 2009 Oct;19(8):521-4. doi: 10.1016/j.numecd.2009.07.005. Epub 2009 Aug 19. Nutr Metab Cardiovasc Dis. 2009. PMID: 19695857 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

28 results

Results by year